Beyond T-Cells: Functional Characterization of CTLA-4 Expression in Immune and Non-Immune Cell Types.
Beyond T-Cells: Functional Characterization of CTLA-4 Expression in Immune and Non-Immune Cell Types.
复制标题
DOI:
10.3389/fimmu.2020.608024
复制
发表时间:
2020
影响因子:
7.3
通讯作者:
Decker WK
中科院分区:
文献类型:
--
作者:
Oyewole-Said D;Konduri V;Vazquez-Perez J;Weldon SA;Levitt JM;Decker WK
The immune response consists of a finely-tuned program, the activation of which must be coupled with inhibitory mechanisms whenever initiated. This ensures tight control of beneficial anti-pathogen and anti-tumor responses while preserving tissue integrity, promoting tissue repair, and safeguarding against autoimmunity. A cogent example of this binary response is in the mobilization of co-stimulatory and co-inhibitory signaling in regulating the strength and type of a T-cell response. Of particular importance is the costimulatory molecule CD28 which is countered by CTLA-4. While the role of CD28 in the immune response has been thoroughly elucidated, many aspects of CTLA-4 biology remain controversial. The expression of CD28 is largely constrained to constitutive expression in T-cells and as such, teasing out its function has been somewhat simplified by a limited and specific expression profile. The expression of CTLA-4, on the other hand, while reported predominantly in T-cells, has also been described on a diverse repertoire of cells within both lymphoid and myeloid lineages as well as on the surface of tumors. Nonetheless, the function of CTLA-4 has been mostly described within the context of T-cell biology. The focus on T-cell biology may be a direct result of the high degree of amino acid sequence homology and the co-expression pattern of CD28 and CTLA-4, which initially led to the discovery of CTLA-4 as a counter receptor to CD28 (for which a T-cell-activating role had already been described). Furthermore, observations of the outsized role of CTLA-4 in Treg-mediated immune suppression and the striking phenotype of T-cell hyperproliferation and resultant disease in CTLA-4−/− mice contribute to an appropriate T-cell-centric focus in the study of CTLA-4. Complete elucidation of CTLA-4 biology, however, may require a more nuanced understanding of its role in a context other than that of T-cells. This makes particular sense in light of the remarkable, yet limited utility of anti-CTLA-4 antibodies in the treatment of cancers and of CTLA-4-Ig in autoimmune disorders like rheumatoid arthritis. By fully deducing the biology of CTLA-4-regulated immune homeostasis, bottlenecks that hinder the widespread applicability of CTLA-4-based immunotherapies can be resolved.
登录
查看更多内容
DOI:
10.4049/jimmunol.1401876
发表时间:
2015-03-01
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Hou TZ;Qureshi OS;Wang CJ;Baker J;Young SP;Walker LS;Sansom DM
通讯作者:
Sansom DM
影响因子:
2.9
作者:
Bradshaw, JD;Lu, P;Kurtz, SE
通讯作者:
Kurtz, SE
影响因子:
3.7
作者:
Fathima, Nusrath;Narne, Parimala;Ishaq, Mohammed
通讯作者:
Ishaq, Mohammed
影响因子:
64.8
作者:
BRUNET, JF;DENIZOT, F;GOLSTEIN, P
通讯作者:
GOLSTEIN, P
影响因子:
4.4
作者:
Baroja, ML;Vijayakrishnan, L;Kuchroo, VK
通讯作者:
Kuchroo, VK